Latest News in the pharma Industry

Top Stories

Hopes dashed for new Alzheimer drug

Hopes dashed for new Alzheimer drug

23 Nov 2016

Lilly's solanezumab fails to meet primary endpoint of Phase III study.

Read more 
Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

2 Nov 2016

Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders.

Read more 
Fighting cancer with the power of immunity

Fighting cancer with the power of immunity

24 Oct 2016

New treatment elicits two-pronged immune response that destroys tumors in mice.

Read more 
Pfizer announces US availability of biosimilar Inflectra

Pfizer announces US availability of biosimilar Inflectra

21 Oct 2016

Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US.

Read more 
Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector

Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector

10 Oct 2016

The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel.

Read more 
Pfizer decides to remain as one company

Pfizer decides to remain as one company

26 Sep 2016

Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility.

Read more 
Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance

Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance

25 Sep 2016

Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance.

Read more 
GSK announces significant new investment in UK manufacturing network

GSK announces significant new investment in UK manufacturing network

27 Jul 2016

Investment in advanced manufacturing of new respiratory and biopharmaceuticals portfolio.

Read more 
BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

27 Jun 2016

This milestone marks the sixth Breakthrough Therapy Designation for Opdivo.

Read more 
Shire completes combination with Baxalta

Shire completes combination with Baxalta

3 Jun 2016

Combined company expected to deliver double-digit compound annual top-line growth with over $20 billion in annual revenues by 2020.

Read more 
Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals

Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals

25 Apr 2016

Brings more than three decades of leadership and operations experience in healthcare.

Read more 
Pfizer–Allergan merger agreement terminated

Pfizer–Allergan merger agreement terminated

6 Apr 2016

Allergan reiterates strong standalone growth profile and strategy following termination of Pfizer transaction.

Read more